Hari Menon

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)

Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh et al. · Leukemia · 2021 · 101 citations · Full text

Medicine, Hematology, Oncology +15

A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer

George R. Blumenschein, Fairooz F. Kabbinavar, Hari Menon et al. · Annals of Oncology · 2011 · 92 citations

Medicine, Oncology, Pharmacology +12

Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors

S.-H. Kim, Hari Menon, Saengsuree Jootar et al. · Haematologica · 2014 · 70 citations · Full text

Medicine, Oncology, Pharmacology +13

Cytogenetic Profile in 7209 Indian Patients with <i>de novo</i> Acute Leukemia: A Single Centre Study from India

P. S. Kadam Amare, H. K. Jain, Sharayu Kabre et al. · Journal of Cancer Therapy · 2016 · 48 citations · Full text

Life Sciences, Genetics, Hematology +16

Clinicopathologic study and outcome analysis of thyroid lymphomas: Experience from a tertiary cancer center

Rakesh Katna, Tanuja Shet, Manju Sengar et al. · Head & Neck · 2012 · 43 citations

Medicine, Oncology, Pathology +16